Pathophysiology and Prevention of Ventriculostomy-Related Infections: A Review.
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
received:
03
05
2024
accepted:
07
08
2024
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
12
9
2024
Statut:
aheadofprint
Résumé
This qualitative review aims to summarize current knowledge on ventriculostomy-related infection (VRI) pathophysiology and its prevention. VRI generally occurs at day 10, mainly because of Gram-positive cocci, after a cerebrospinal fluid leak. Skin microbiota and biofilm seem to play a major role in VRI pathogenesis. Colonization of external ventricular drain by biofilm is universal and occurs quickly after catheter insertion. However, pathogens from the skin are more often associated with VRI than commensal bacteria. A review of proposed preventive measures shows that none has proven to be fully efficient. Periprocedural and prolonged systemic prophylactic antimicrobials have not shown to prevent VRIs and may promote the emergence of more resistant or pathogenic strains. Antimicrobial and silver-impregnated external ventricular drains, although promising, have not demonstrated preventive effects and may modify bacterial ecology. These results are consistent with the proposed pathophysiology. Finally, we will present a few propositions for future research that may help in improving our knowledge and thus better prevent VRIs. Until then, given the available data, limiting the duration of ventricular drainage may be the most attainable option to prevent VRIs.
Identifiants
pubmed: 39264162
doi: 10.1227/neu.0000000000003181
pii: 00006123-990000000-01342
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © Congress of Neurological Surgeons 2024. All rights reserved.
Références
Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34-e65.
Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol. 2008;255(11):1617-1624.
Lyke KE, Obasanjo OO, Williams MA, O’Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis. 2001;33(12):2028-2033.
Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis. 2015;15:3.
Sundbärg G, Kjällquist Å, Lundberg N, Pontén U. Complications due to prolonged ventricular fluid pressure recording in clinical practice. In: Brock M, Dietz H, eds. Intracranial Pressure. Springer; 1972:348-352.
Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg. 1997;87(2):247-251.
Bayston R. Analysis of twenty-four “failures” of BactisealTM antimicrobial shunts reported to FDA. Cerebrospinal Fluid Res. 2006;3(S1):S53.
Lozier AP, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170-182; discussion 181-182.
Mounier R, Birnbaum R, Cook F, et al. Natural history of ventriculostomy-related infection under appropriate treatment and risk factors of poor outcome: a retrospective study. J Neurosurg. 2019;131(4):1052-1061.
Bari ME, Haider G, Malik K, Waqas M, Mahmood SF, Siddiqui M. Outcomes of post-neurosurgical ventriculostomy-associated infections. Surg Neurol Int. 2017;8:124.
Walek KW, Leary OP, Sastry R, et al. Risk factors and outcomes associated with external ventricular drain infections. Infect Control Hosp Epidemiol. 2022;43(12):1859-1866.
Kirby A, Berry C, West R. Antibiotic consumption and Enterobacteriaceae skin colonization in hospitalized adults. J Hosp Infect. 2017;95(1):65-68.
Jamjoom AAB, Joannides AJ, Poon MTC, et al. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry. 2018;89(2):120-126.
Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310(9):553-559.
Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJJ. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien). 2008;150(3):209-214; discussion 214.
Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85(3):419-424.
Park P, Garton HJL, Kocan MJ, Thompson BG. Risk of infection with prolonged ventricular catheterization. Neurosurgery. 2004;55(3):594-601; discussion 599-601.
Mounier R, Lobo D, Cook F, et al. From the skin to the brain: pathophysiology of colonization and infection of external ventricular drain, a prospective observational study. PLoS ONE. 2015;10(11):e0142320.
Mounier R, Lobo D, Cook F, et al. Clinical, biological, and microbiological pattern associated with ventriculostomy-related infection: a retrospective longitudinal study. Acta Neurochir. 2015;157(12):2209-2217.
Aucoin PJ, Kotilainen HR, Gantz NM, Davidson R, Kellogg P, Stone B. Intracranial pressure monitors. Epidemiologic study of risk factors and infections. Am J Med. 1986;80(3):369-376.
Scheithauer S, Bürgel U, Ryang YM, et al. Prospective surveillance of drain associated meningitis/ventriculitis in a neurosurgery and neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2009;80(12):1381-1385.
Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244-253.
Kramer A, Dissemond J, Kim S, et al. Consensus on wound antisepsis: update 2018. Skin Pharmacol Physiol. 2018;31(1):28-58.
Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.
Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95-108.
Ramírez P, Gordón M, Soriano A, et al. Assessment of the in vivo formation of biofilm on external ventricular drainages. Eur J Clin Microbiol Infect Dis. 2013;32(11):1437-1443.
Roujansky A, Kapandji N, Diop S, et al. Prospective comparative study of external ventricular drain catheter colonization: antibiotic-impregnated versus conventional drains. World Neurosurg. 2023;176:e438-e446.
Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510-543.
Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 1948;29(1):58-69.
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337-341.
Louveau A, Harris TH, Kipnis J. Revisiting the mechanisms of CNS immune privilege. Trends Immunol. 2015;36(10):569-577.
Rua R, McGavern DB. Advances in meningeal immunity. Trends Mol Med. 2018;24(6):542-559.
Roujansky A, Diop S, Pasqueron J, et al. Impact of subarachnoid hemorrhage in ventriculostomy-related infections prospective comparison of two neurosurgical injury contexts. World Neurosurg. 2024;183:e136-e144.
SFAR (Société Française d’Anesthésie et de Réanimation). Mise à jour de la Recommandation Formalisée d’Experts Antibioprophylaxie 2017; 2018. Accessed January 28, 2020. https://sfar.org/mise-a-jour-de-la-rfe-antibioprophylaxie-2017/
Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr. 2008;1(1):48-56.
Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery. 1994;34(1):87-92.
Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis. 1993;17(1):98-103.
Camacho EF, Boszczowski Í, Basso M, et al. Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 2011;39(1):47-51.
Wyler AR, Kelly WA. Use of antibiotics with external ventriculostomies. J Neurosurg. 1972;37(2):185-187.
Mounier R, Kapandji N, Gricourt G, et al. Assessment of bacterial colonization of intracranial pressure transducers: a prospective study. Neurocrit Care. 2021;34(3):814-824.
Clark WC, Muhlbauer MS, Lowrey R, Hartman M, Ray MW, Watridge CB. Complications of intracranial pressure monitoring in trauma patients. Neurosurgery. 1989;25(1):20-24.
Alleyne CH, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47(5):1124-1129; discussion 1127-1129.
Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961;50:161-168.
Relman DA. The human microbiome: ecosystem resilience and health. Nutr Rev. 2012;70(Suppl 1):S2-S9.
Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: a randomised study. Acta Neurochir Suppl. 1998;71:146-148.
Sonabend AM, Korenfeld Y, Crisman C, Badjatia N, Mayer SA, Connolly ES. Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review. Neurosurgery. 2011;68(4):996-1005.
Murphy RKJ, Liu B, Srinath A, et al. No additional protection against ventriculitis with prolonged systemic antibiotic prophylaxis for patients treated with antibiotic-coated external ventricular drains. J Neurosurg. 2015;122(5):1120-1126.
Bayston R, Ashraf W, Fisher L. Prevention of infection in neurosurgery: role of “antimicrobial” catheters. J Hosp Infect. 2007;65(Suppl 2):39-42.
Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother. 2004;53(5):778-782.
Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725-730.
Harrop JS, Sharan AD, Ratliff J, et al. Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery. 2010;67(1):187-191; discussion 191.
Wong GKC, Ip M, Poon WS, Mak CWK, Ng RYT. Antibiotics-impregnated ventricular catheter versus systemic antibiotics for prevention of nosocomial CSF and non-CSF infections: a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry. 2010;81(10):1064-1067.
Pople I, Poon W, Assaker R, et al. Comparison of infection rate with the use of antibiotic-impregnated vs standard extraventricular drainage devices: a prospective, randomized controlled trial. Neurosurgery. 2012;71(1):6-13.
Wang X, Dong Y, Qi XQ, Li YM, Huang CG, Hou LJ. Clinical review: efficacy of antimicrobial-impregnated catheters in external ventricular drainage - a systematic review and meta-analysis. Crit Care. 2013;17(4):234.
Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry. 1989;52(5):605-609.
Mounier R, Lang E, Hulin A, et al. Durability of antimicrobial activity of antibiotic-impregnated external ventricular drains: a prospective study. J Antimicrob Chemother. 2019;74(11):3328-3336.
Lang E, Hulin A, Egbeola-Martial J, et al. In vitro study of factors influencing the duration of antimicrobial protection of antimicrobial-impregnated external ventricular drains. J Antimicrob Chemother. 2022;77(3):682-688.
Stevens EA, Palavecino E, Sherertz RJ, Shihabi Z, Couture DE. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J Neurosurg. 2010;113(1):86-92.
Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg. 2015;122(5):1096-1112.
Bayston R, Vera L, Mills A, Ashraf W, Stevenson O, Howdle SM. In vitro antimicrobial activity of silver-processed catheters for neurosurgery. J Antimicrob Chemother. 2010;65(2):258-265.
Pino-Ramos VH, Audifred-Aguilar JC, Sánchez-Obregón R, Bucio E. Antimicrobial polyurethane catheters synthesized by grafting-radiation method doped with silver nanoparticles. Reactive Funct Polym. 2021;167:105006.
Keong NCH, Bulters DO, Richards HK, et al. The SILVER (Silver impregnated line versus EVD randomized trial): a double-blind, prospective, randomized, controlled trial of an intervention to reduce the rate of external ventricular drain infection. Neurosurgery. 2012;71(2):394-404; discussion 403-404.
Atkinson RA, Fikrey L, Vail A, Patel HC. Silver-impregnated external-ventricular-drain-related cerebrospinal fluid infections: a meta-analysis. J Hosp Infect. 2016;92(3):263-272.
Diop S, Roujansky A, Kallel H, Mounier R. Prevention of ventriculostomy related infection: effectiveness of impregnated biomaterial. Int J Mol Sci. 2023;24(5):4819.
Saunders RL, Lyons TA. External ventricular drainage. A technical note. Crit Care Med. 1979;7(12):556-558.
Asaad SK, Bjarkam CR. The Aalborg Bolt-Connected Drain (ABCD) study: a prospective comparison of tunnelled and bolt-connected external ventricular drains. Acta Neurochir. 2019;161(1):33-39.
Garg K, Gupta D, Singh M, Chandra PS, Kale SS. Comparison of a bolt-connected external ventricular drain with a tunneled external ventricular drain — a narrative review and meta-analysis. Neurosurg Rev. 2022;45(2):937-949.
Bergdal O, Springborg JB, Holst AV, et al. Accuracy of tunnelated vs. bolt-connected external ventricular drains. Clin Neurol Neurosurg. 2013;115(10):1972-1975.
Wong GKC, Poon WS, Wai S, Yu LM, Lyon D, Lam JMK. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2002;73(6):759-761.
Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327(15):1062-1068.
Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33(9):1567-1572.
Cho NA, Strayer K, Dobson B, McDonald B. Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness. Gut Microbes. 2024;16(1):2351478.
Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168(2):400-407.
Moayyedi P, Surette MG, Kim PT, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102-109.e6.
Reid G, Howard J, Gan BS. Can bacterial interference prevent infection? Trends Microbiol. 2001;9(9):424-428.
Klemm P, Hancock V, Schembri MA. Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972. Infect Immun. 2007;75(8):3688-3695.
Sundén F, Håkansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010;184(1):179-185.
Chopra T, Hecht G, Tillotson G. Gut microbiota and microbiota-based therapies for Clostridioides difficile infection. Front Med (Lausanne). 2022;9:1093329.
Couffin S, Lobo D, Cook F, et al. Coagulase-negative staphylococci are associated to the mild inflammatory pattern of healthcare-associated meningitis: a retrospective study. Eur J Clin Microbiol Infect Dis. 2018;37(4):755-763.
Pitlik SD, Koren O. How holobionts get sick—toward a unifying scheme of disease. Microbiome. 2017;5(1):64.